Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 2/20 | 0.42 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.42 |
| ▸ | IRAK4 | Q9NWZ3 | 7/20 | 0.42 |
| ▸ | DCPS | Q96C86 | 2/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | IKBKB | O14920 | 3/20 | 0.40 |
| ▸ | CHUK | O15111 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL619089 | 0.90 | ACP1 (0.41) | PIM1PIM2IRAK4DCPSDHFR | |
| SCHEMBL618750 | 0.89 | DCPS (0.48) | DCPSDHFR | |
| SCHEMBL621384 | 0.89 | DCPS (0.48) | DCPSDHFR | |
| SCHEMBL619531 | 0.88 | DCPS (0.47) | DCPSDHFR | |
| Hydrochloric Acid SCHEMBL619258 | 0.88 | DCPS (0.47) | DCPSDHFR | |
| SCHEMBL618000 | 0.85 | CHRNB2 (0.52) | PIM1PIM2IRAK4F2PLG | |
| SCHEMBL10257366 | 0.85 | CHRNB2 (0.52) | PIM1PIM2IRAK4F2PLG | |
| SCHEMBL10257173 | 0.85 | CHRNB2 (0.52) | PIM1PIM2IRAK4F2PLG | |
| SCHEMBL2514003 | 0.83 | CHEK2 (0.40) | PIM1PIM2IRAK4IKBKBCHUK | |
| SCHEMBL21281312 | 0.82 | DCPS (0.40) | DCPSDHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102933081-B | Sweet flavor modifier | SENOMYX, INC. (US) | 2016-04-13 | — | — | CN | disclosed |